Skip to main content


Table 2 Summary of key conclusions

From: Challenges in the translation and commercialization of cell therapies

Key Challenges
• Pre-market: Persevering through lengthy developmental timelines and navigating the regulatory environment
• Post-market: Securing reasonable reimbursement and encouraging adoption
• Manufacturing: Scaling up production, addressing distribution logistics and managing cost of goods sold
• Interactions among these various challenges complicate the process of commercializing cell therapies
Preliminary Best Practices Policy Considerations
• Preparing for commercialization early in the development process • Improving coordination and communication between relevant agencies
• Adopting strategies to use capital efficiently • Promoting international harmonization of cell therapy regulations